(Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age ...
Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and ...
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...
Launched in 2003 as part of CDC’s strategy for addressing the worldwide threat ... including playing a pivotal role in ...
AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK's proprietary AS01E adjuvant.
The CDC is attempting to get the COVID-19 shot into more arms by asking physicians and pharmacists to recommend the updated ...
Pneumococcal vaccines are recommended for adults age 65 and older, smokers, younger people with weak immune systems, as well ...
Yes, the Centers for Disease Control and Prevention (CDC) does indeed recommend the pneumococcal vaccines for pneumonia for ...
The Allegheny County Health Department launched a new respiratory virus dashboard Monday. Residents can use the tool to find ...
ILLINOIS - The Illinois Department of Public Health reminds the public that along with fall, October brings the start of the traditional respiratory virus season.